PortfoliosLab logo
CI vs. HUM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CI and HUM is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.4

Performance

CI vs. HUM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cigna Corporation (CI) and Humana Inc. (HUM). The values are adjusted to include any dividend payments, if applicable.

5,000.00%6,000.00%7,000.00%8,000.00%9,000.00%10,000.00%11,000.00%NovemberDecember2025FebruaryMarchApril
10,946.40%
5,589.43%
CI
HUM

Key characteristics

Sharpe Ratio

CI:

-0.12

HUM:

-0.40

Sortino Ratio

CI:

0.01

HUM:

-0.29

Omega Ratio

CI:

1.00

HUM:

0.96

Calmar Ratio

CI:

-0.12

HUM:

-0.29

Martin Ratio

CI:

-0.27

HUM:

-0.65

Ulcer Index

CI:

12.13%

HUM:

25.79%

Daily Std Dev

CI:

26.75%

HUM:

41.99%

Max Drawdown

CI:

-84.34%

HUM:

-85.10%

Current Drawdown

CI:

-7.66%

HUM:

-51.29%

Fundamentals

Market Cap

CI:

$91.38B

HUM:

$31.82B

EPS

CI:

$12.12

HUM:

$10.15

PE Ratio

CI:

27.78

HUM:

25.97

PEG Ratio

CI:

0.65

HUM:

0.80

PS Ratio

CI:

0.37

HUM:

0.27

PB Ratio

CI:

2.22

HUM:

1.94

Total Revenue (TTM)

CI:

$188.97B

HUM:

$88.15B

Gross Profit (TTM)

CI:

$188.97B

HUM:

$88.15B

EBITDA (TTM)

CI:

$8.34B

HUM:

$2.05B

Returns By Period

In the year-to-date period, CI achieves a 22.17% return, which is significantly higher than HUM's 5.91% return. Over the past 10 years, CI has outperformed HUM with an annualized return of 10.78%, while HUM has yielded a comparatively lower 4.84% annualized return.


CI

YTD

22.17%

1M

5.95%

6M

6.45%

1Y

-3.07%

5Y*

13.98%

10Y*

10.78%

HUM

YTD

5.91%

1M

-1.85%

6M

4.28%

1Y

-14.22%

5Y*

-5.48%

10Y*

4.84%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CI vs. HUM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CI
The Risk-Adjusted Performance Rank of CI is 4343
Overall Rank
The Sharpe Ratio Rank of CI is 4646
Sharpe Ratio Rank
The Sortino Ratio Rank of CI is 3838
Sortino Ratio Rank
The Omega Ratio Rank of CI is 3838
Omega Ratio Rank
The Calmar Ratio Rank of CI is 4545
Calmar Ratio Rank
The Martin Ratio Rank of CI is 4747
Martin Ratio Rank

HUM
The Risk-Adjusted Performance Rank of HUM is 3333
Overall Rank
The Sharpe Ratio Rank of HUM is 3030
Sharpe Ratio Rank
The Sortino Ratio Rank of HUM is 3030
Sortino Ratio Rank
The Omega Ratio Rank of HUM is 2929
Omega Ratio Rank
The Calmar Ratio Rank of HUM is 3434
Calmar Ratio Rank
The Martin Ratio Rank of HUM is 4040
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CI vs. HUM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cigna Corporation (CI) and Humana Inc. (HUM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for CI, currently valued at -0.12, compared to the broader market-2.00-1.000.001.002.003.00
CI: -0.12
HUM: -0.40
The chart of Sortino ratio for CI, currently valued at 0.01, compared to the broader market-6.00-4.00-2.000.002.004.00
CI: 0.01
HUM: -0.29
The chart of Omega ratio for CI, currently valued at 1.00, compared to the broader market0.501.001.502.00
CI: 1.00
HUM: 0.96
The chart of Calmar ratio for CI, currently valued at -0.12, compared to the broader market0.001.002.003.004.005.00
CI: -0.12
HUM: -0.29
The chart of Martin ratio for CI, currently valued at -0.27, compared to the broader market-10.00-5.000.005.0010.0015.0020.00
CI: -0.27
HUM: -0.65

The current CI Sharpe Ratio is -0.12, which is higher than the HUM Sharpe Ratio of -0.40. The chart below compares the historical Sharpe Ratios of CI and HUM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00NovemberDecember2025FebruaryMarchApril
-0.12
-0.40
CI
HUM

Dividends

CI vs. HUM - Dividend Comparison

CI's dividend yield for the trailing twelve months is around 1.70%, more than HUM's 1.32% yield.


TTM20242023202220212020201920182017201620152014
CI
Cigna Corporation
1.70%2.03%1.64%1.35%1.74%0.02%0.02%0.02%0.02%0.03%0.03%0.04%
HUM
Humana Inc.
1.32%1.40%0.77%0.62%0.60%0.61%0.60%0.70%0.76%0.43%0.64%0.77%

Drawdowns

CI vs. HUM - Drawdown Comparison

The maximum CI drawdown since its inception was -84.34%, roughly equal to the maximum HUM drawdown of -85.10%. Use the drawdown chart below to compare losses from any high point for CI and HUM. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%NovemberDecember2025FebruaryMarchApril
-7.66%
-51.29%
CI
HUM

Volatility

CI vs. HUM - Volatility Comparison

The current volatility for Cigna Corporation (CI) is 8.09%, while Humana Inc. (HUM) has a volatility of 17.54%. This indicates that CI experiences smaller price fluctuations and is considered to be less risky than HUM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
8.09%
17.54%
CI
HUM

Financials

CI vs. HUM - Financials Comparison

This section allows you to compare key financial metrics between Cigna Corporation and Humana Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items